Health Innovation and Technology Limited - Period Ending 2016-08-31

Health Innovation and Technology Limited - Period Ending 2016-08-31


Health Innovation and Technology Limited SC484494 false true 2015-09-01 2016-08-31 2016-08-31 SC484494 2015-09-01 2016-08-31 SC484494 2016-08-31 SC484494 uk-bus:OrdinaryShareClass1 2016-08-31 SC484494 uk-bus:Director1 2015-09-01 2016-08-31 SC484494 uk-bus:Director2 2015-09-01 2016-08-31 SC484494 uk-bus:OrdinaryShareClass1 2015-09-01 2016-08-31 SC484494 uk-bus:EntityAccountantsOrAuditors 2015-09-01 2016-08-31 SC484494 uk-gaap:OfficeEquipment 2015-09-01 2016-08-31 SC484494 uk-gaap:PlantMachinery 2015-09-01 2016-08-31 SC484494 2015-08-31 SC484494 2015-08-31 SC484494 uk-bus:OrdinaryShareClass1 2015-08-31 iso4217:GBP xbrli:shares

Registration number: SC484494

Health Innovation and Technology Limited

Unaudited Abbreviated Accounts

for the Year Ended 31 August 2016
 

AIMS, Simon Cox
134
Norwich Road
Stoke Holy Cross
Norwich
NR14 8QJ

 

Health Innovation and Technology Limited
Contents

Accountants' Report

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

3 to 4

 

The following reproduces the text of the accountants' report in respect of the company's annual financial statements, from which the abbreviated accounts (set out on pages 2 to 4) have been prepared.

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Health Innovation and Technology Limited
for the Year Ended 31 August 2016

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Health Innovation and Technology Limited for the year ended 31 August 2016 set out on pages from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at icaew.com/membershandbook.

This report is made solely to the Board of Directors of Health Innovation and Technology Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Health Innovation and Technology Limited and state those matters that we have agreed to state to them, as a body, in this report in accordance with AAF 2/10 as detailed at icaew.com/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Health Innovation and Technology Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Health Innovation and Technology Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Health Innovation and Technology Limited. You consider that Health Innovation and Technology Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Health Innovation and Technology Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

AIMS, Simon Cox
134
Norwich Road
Stoke Holy Cross
Norwich
NR14 8QJ

31 October 2016

 

Health Innovation and Technology Limited
(Registration number: SC484494)
Abbreviated Balance Sheet at 31 August 2016

   

Note

   

2016
£

   

2015
£

 

Fixed assets

 

             

Tangible fixed assets

 

   

8,042

   

-

 

Current assets

 

             

Debtors

 

   

764

   

1,000

 

Cash at bank and in hand

 

   

4,345

   

-

 
   

   

5,109

   

1,000

 

Creditors: Amounts falling due within one year

 

   

(10,977)

   

-

 

Net current (liabilities)/assets

 

   

(5,868)

   

1,000

 

Net assets

 

   

2,174

   

1,000

 

Capital and reserves

 

             

Called up share capital

 

3

   

1,000

   

1,000

 

Profit and loss account

 

   

1,174

   

-

 

Shareholders' funds

 

   

2,174

   

1,000

 

For the year ending 31 August 2016 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime .

Approved by the Board on 31 October 2016 and signed on its behalf by:

.........................................
Ian Galloway
Director

.........................................
Scott McKenzie
Director

The notes on pages 3 to 4 form an integral part of these financial statements.
Page 2

 

Health Innovation and Technology Limited
Notes to the Abbreviated Accounts for the Year Ended 31 August 2016
......... continued

1

Accounting policies

Basis of preparation

The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (Effective January 2015).

Turnover

Turnover represents amounts chargeable, net of value added tax, in respect of the sale of goods and services to customers.

Depreciation

Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic lives as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% reducing balance

Office equipment

20% reducing balance

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as interest expense in the profit and loss account.

2

Fixed assets

   

Tangible assets
£

   

Total
£

 

Cost

           

Additions

 

8,042

   

8,042

 

At 31 August 2016

 

8,042

   

8,042

 

Depreciation

           

At 31 August 2016

 

-

   

-

 

Net book value

           

At 31 August 2016

 

8,042

   

8,042

 
 

Health Innovation and Technology Limited
Notes to the Abbreviated Accounts for the Year Ended 31 August 2016
......... continued

3

Share capital

Allotted, called up and fully paid shares

 

2016

2015

   

No.

   

£

   

No.

   

£

 

Ordinary of £1 each

 

1,000

   

1,000

   

1,000

   

1,000